Your browser doesn't support javascript.
loading
Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France.
Duru, G; Carrat, F; Pribil, C; Bricaire, F; Pujol, P; Robert, J; Lafuma, A.
Affiliation
  • Duru G; Cyklad Group, Rillieux la Pape, France.
  • Carrat F; University Pierre et Marie Curie, Paris 6, Paris, France.
  • Pribil C; GSK, Marly Le Roi, France.
  • Bricaire F; Hospital La Pitié-Salpetrière, Paris, France.
  • Pujol P; GSK, Marly Le Roi, France.
  • Robert J; Cemka-Eval, Bourg la Reine, France.
  • Lafuma A; Cemka-Eval, Bourg la Reine, France.
Value Health ; 17(7): A678, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27202501
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Francia